Chiron Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $111 Million distributed in 119 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $23M, Spdr Ser Tr Spdr S&P Biotech E with a value of $8.78M, Nike, Inc. with a value of $3.35M, Aflac Inc with a value of $2.6M, and Cvs Health Corp with a value of $2.55M.

Examining the 13F form we can see an increase of $7.9M in the current position value, from $103M to 111M.

Below you can find more details about Chiron Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $111 Million
Healthcare: $35 Million
ETFs: $14.9 Million
Consumer Cyclical: $10.4 Million
Financial Services: $9.58 Million
Consumer Defensive: $9.36 Million
Energy: $7.75 Million
Communication Services: $6.61 Million
Basic Materials: $6.04 Million
Other: $11.3 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 119
  • Current Value $111 Million
  • Prior Value $103 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 14 stocks
  • Additional Purchases 37 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 52 stocks
Track This Portfolio

Track Chiron Capital Management, LLC Portfolio

Follow Chiron Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Capital Management, LLC with notifications on news.